OpenAI Launches Guaranteed Capacity Offering to Secure Compute for Enterprise Customers Mamata Banterjee Takes Legal Role in PostPoll Violence Case West Bengals Political Landscape Under Scrutiny cbdMD YCBD Delivers Q1 2026 Beat EPS 004 vs 006 Expected Portuguese Liqueur Brand Defeats Louis Vuitton in Trademark Dispute Live LYV Stock Up 088 Key Resistance at 17266 20260520 California Judge Orders Kars4Kids to Disclose Jewish Charity Ties in Ads or Face Ban Paul Tudor Jones Says Fed Rate Cuts Under Warsh Have No Chance Amid Persistent Inflation White House Announces New Agricultural and Rare Earths Deals Following TrumpXi Summit China Signals Tariff Cuts ADP Report Shows Private Payrolls Rose by 109000 in April Exceeding Estimates Fed Dissenters Voice Opposition to Signaling Rate Cut Cite Uncertainty Kyoto University iPS Cell Research Under Scrutiny Director Labels Work Repetitive Corporate Embrace of Prediction Markets Unshaken by Regulatory Uncertainty SP 500 Inches Higher as Healthcare and Tech Lead Broad Gains Trumps Approval Rating Remains Below 39 in Latest Polls With More Declines Than Gains SUNC Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds Myriad Genetics Q1 2026 Earnings EPS Miss Highlights Continued Operational Challenges ETR Q1 2026 Earnings Slight EPS Miss Amid Solid Utility Performance Petco WOOF Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 6 AWK Q1 2026 Earnings EPS Misses Estimates but Stock Edges Higher on Regulatory Strength PutinXi Talks Could Revive Stalled Power of Siberia 2 Gas Pipeline Amid Iran Conflict Digital Wallets Poised to Redefine Trust Infrastructure in Banking Alibaba Unveils Upgraded Zhenwu AI Chip and New Large Language Model Australian Taxpayers Subsidise Big Minings Fossil Fuel Use by 4bn a Year Report Reveals Latin American Leaders at WUF13 Push for New Housing Finance Models and ClimateResilient Urban Development Paul Tudor Jones Says Theres No Chance Warsh Would Cut Rates at the Fed UK Spy Chief Warns West Faces Moment of Consequence Geopolitical Risks Intensify Arvinas Inc ARVN Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Pipeline Advances